EUVIMEDSkopri EUVIMED
Multizentrische StudieOpen access

Outcomes of patients with acute liver failure listed for liver transplantation: A multicenter prospective cohort analysis

Constantine J Karvellas iD, Thomas M Leventhal, Jorge L Rakela iD, Jingwen Zhang, Valerie Durkalski, K Rajender Reddy iD, Robert J Fontana, R Todd Stravitz, John R Lake, William M Lee iD, Justin R Parekh

Liver Transplantation · 2023-03 · 29 (3) · 318-330

DOI: 10.1002/lt.26563 ↗

At a glance

Multizentrische Studie in Liver Transplantation, published online on 2022-09-14. Written by Constantine J Karvellas and 10 co-authors. Institution: Division of Gastroenterology (Liver Unit), Department of Critical Care Medicine , University of Alberta , Edmonton , Alberta , Canada. Major MEDLINE topics: Liver Transplantation, End Stage Liver Disease, Liver Failure, Acute. Cited 81 times so far (Crossref); 29 references. The full text is freely available in PubMed Central. Funded by: NIDDK NIH HHS.

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Liver transplantation (LT) is a life‐saving treatment for patients with acute liver failure (ALF). Currently, there are few detailed data regarding long‐term outcomes after LT for ALF. We combined prospective data from the Acute Liver Failure Study Group (ALFSG) Registry with those of the Scientific Registry of Transplant Recipients (SRTR) to assess outcomes among consecutive patients with ALF listed for LT. Cohort analysis of detailed pretransplantation data for patients listed for LT for ALF in the ALFSG Registry between January 1998 and October 2018 matched with transplantation‐related data from the SRTR. Primary outcomes were 1‐ and 3‐year post‐LT patient survival. Secondary outcome was receipt of LT; independent associations with successful receipt of LT were determined using multivariable logistic regression. Of 624 patients with ALF listed for LT, 398 (64%) underwent LT, 100 (16%) died without LT, and 126 (20%) recovered spontaneously. Among LT recipients, etiologies included seronegative/indeterminate (22%), drug‐induced liver injury (18%), acetaminophen overdose (APAP; 16%), and viral hepatitis (15%). The 1‐ and 3‐year post‐LT patient survival rates were 91% and 90%, respectively. Comparing those dying on the waiting list versus with those who received LT, the former had more severe multiorgan failure, reflected by increased vasopressor use (65% vs. 22%), mechanical ventilation (84% vs. 57%), and renal replacement therapy (57% vs. 30%; p < 0.0001 for all). After adjusting for relevant covariates, age (adjusted odds ratio [aOR] 1.02, 95% confidence interval [CI] 1.00–1.04), APAP etiology (aOR 2.72, 95% CI 1.42–5.23), requirement for vasopressors (aOR 4.19, 95% CI 2.44–7.20), Grade III/IV hepatic encephalopathy (aOR 2.47, 95% CI 1.29–4.72), and Model for End‐Stage Liver Disease (MELD) scores (aOR 1.05, 95% CI 1.02–1.09; p < 0.05 for all) were independently associated with death without receipt of LT. Post‐LT outcomes for ALF are excellent in this cohort of very ill patients. The development of multiorgan failure while on the transplantation list and APAP ALF etiology were associated with a lower likelihood of successful receipt of LT.

Subjects

MeSH terms (MEDLINE)

Liver TransplantationEnd Stage Liver DiseaseLiver Failure, AcuteHumansAcetaminophenProspective StudiesSeverity of Illness IndexCohort Studies

Substances

Acetaminophen

Authors and institutions

  • Division of Gastroenterology (Liver Unit), Department of Critical Care Medicine , University of Alberta , Edmonton , Alberta , Canada.
  • Division of Gastroenterology, Hepatology, and Nutrition , University of Minnesota , Minneapolis , Minnesota , USA.
  • Division of Gastroenterology and Hepatology , Mayo Clinic Arizona , Phoenix , Arizona , USA.
  • Department of Public Health Sciences , Medical University of South Carolina , Charleston , South Carolina , USA.
  • Division of Gastroenterology and Hepatology , University of Pennsylvania , Philadelphia , Pennsylvania , USA.
  • Division of Gastroenterology, Department of Internal Medicine , University of Michigan Medical Center , Ann Arbor , Michigan , USA.

ORCID profiles: Constantine J Karvellas, Jorge L Rakela, K Rajender Reddy, William M Lee

Funding

  • NIDDK NIH HHS

Cite

APA

Karvellas, C. J., Leventhal, T. M., Rakela, J. L., Zhang, J., Durkalski, V., Reddy, K. R., Fontana, R. J., Stravitz, R. T., Lake, J. R., Lee, W. M., & Parekh, J. R. (2023). Outcomes of patients with acute liver failure listed for liver transplantation: A multicenter prospective cohort analysis. Liver Transplantation, 29(3), 318-330. https://doi.org/10.1002/lt.26563

Vancouver

Karvellas CJ, Leventhal TM, Rakela JL, Zhang J, Durkalski V, Reddy KR, et al. Outcomes of patients with acute liver failure listed for liver transplantation: A multicenter prospective cohort analysis. Liver Transplantation. 2023;29(3):318-330. doi:10.1002/lt.26563

BibTeX
@article{Karvellas2023,
  author = {Karvellas, Constantine J and Leventhal, Thomas M and Rakela, Jorge L and Zhang, Jingwen and Durkalski, Valerie and Reddy, K Rajender and Fontana, Robert J and Stravitz, R Todd and Lake, John R and Lee, William M and Parekh, Justin R},
  title = {Outcomes of patients with acute liver failure listed for liver transplantation: A multicenter prospective cohort analysis},
  journal = {Liver Transplantation},
  year = {2023},
  volume = {29},
  number = {3},
  pages = {318--330},
  doi = {10.1002/lt.26563}
}
Start for free →